Omar Wever‐Pinzon

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.2K citations · Full text

Medicine, Cardiology, Pharmacotherapy +6

Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy

Carolyn Y. Ho, Matthew E. Mealiffe, Richard G. Bach et al. · Journal of the American College of Cardiology · 2020 · 338 citations · Full text

Medicine, Cardiology, Pharmacology +14

Pulsatility and the Risk of Nonsurgical Bleeding in Patients Supported With the Continuous-Flow Left Ventricular Assist Device HeartMate II

Omar Wever‐Pinzon, Craig H. Selzman, Stavros G. Drakos et al. · Circulation Heart Failure · 2013 · 231 citations · Full text

Medicine, Cardiology, Surgery +15

Cardiac Recovery During Long-Term Left Ventricular Assist Device Support

Omar Wever‐Pinzon, Stavros G. Drakos, Stephen H. McKellar et al. · Journal of the American College of Cardiology · 2016 · 203 citations

Medicine, Cardiology, Cardiothoracic Surgery +8

Magnitude and Time Course of Changes Induced by Continuous-Flow Left Ventricular Assist Device Unloading in Chronic Heart Failure

Stavros G. Drakos, Omar Wever‐Pinzon, Craig H. Selzman et al. · Journal of the American College of Cardiology · 2013 · 191 citations

Medicine, Cardiology, Cardiac Rehabilitation +14